Curcumin is a phytochemical isolated from Curcuma longa with potent tumor‐suppressor
activity, which has shown significant efficacy in pre‐clinical and clinical studies. Curcumin …

Cachexia is a multifactorial disease characterized by weight loss via skeletal muscle and
adipose tissue loss, an imbalance in metabolic regulation, and reduced food intake. It is …

Metabolic reprogramming occurs in tumors to foster cancer cell proliferation, survival and
metastasis, but as well at a systemic level affecting the whole organism, eventually leading …

Background and aims Obesity is frequently associated with cirrhosis, and cirrhotic patients
may develop simultaneous loss of skeletal muscle and gain of adipose tissue, culminating in …

Cancer cachexia characterized by a chronic wasting syndrome, involves skeletal muscle
loss and adipose tissue loss and resistance to conventional nutritional support. Cachexia is …

It is estimated that half of all patients with cancer eventually develop a syndrome of
cachexia, with anorexia and a progressive loss of adipose tissue and skeletal muscle mass …

Cachexia is a major characteristic of multiple non-malignant diseases, advanced and
metastatic cancers and it is highly prevalent in pancreatic cancer, affecting almost 70%–80 …

The physical frailty phenotype consists of fatigue, weight loss, and loss of muscle power.
Sarcopenia has been shown to be a major cause of frailty. Six societies including SCWD …

Cancer patients experience symptoms and adverse effects of treatments that may last even
after the end of treatments. Exercise is a safe, non-pharmacological and cost-effective …

Cancer cachexia, consisting of significant skeletal muscle wasting independent of nutritional
intake, is a major concern for patients with solid tumors that affects surgical, therapeutic, and …